Last reviewed · How we verify
Staph Aureus Traumatic Skin Lesion Infection
Approved treatments
- Bactroban · GSK
Bactroban works by inhibiting the production of essential proteins in bacteria, preventing them from reproducing and causing infection.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staph Aureus Traumatic Skin Lesion Infection patent landscape — cliff calendar, originator estates, attackable patents
- Staph Aureus Traumatic Skin Lesion Infection treatment landscape brief
- Staph Aureus Traumatic Skin Lesion Infection treatment updates RSS
Frequently asked questions about Staph Aureus Traumatic Skin Lesion Infection
What drugs treat Staph Aureus Traumatic Skin Lesion Infection?
Tracked treatments include Bactroban.
What is the treatment for Staph Aureus Traumatic Skin Lesion Infection?
Standard treatment for Staph Aureus Traumatic Skin Lesion Infection includes Bactroban. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staph Aureus Traumatic Skin Lesion Infection patent cliff · Staph Aureus Traumatic Skin Lesion Infection CI report
- Treatment: Bactroban · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing